Gabriel Lopez-Valero
Murcia, MU, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 28, 2026
Educational programs based on healthy habits to improve quality of life and psychosocial profile in women with multiple sclerosis: The ADVICE protocol study.
Journal: Contemporary clinical trials
Published: January 28, 2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective study.
Journal: Therapeutic advances in neurological disorders
Published: January 09, 2026
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.
Journal: Therapeutic advances in neurological disorders
Published: November 09, 2025
Corrigendum: Intrafamilial variability in SLC6A1-related neurodevelopmental disorders.
Journal: Frontiers in neuroscience
Published: July 31, 2023
Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study.
Journal: Neurology and therapy
Published: June 16, 2023
Intrafamilial variability in SLC6A1-related neurodevelopmental disorders.
Journal: Frontiers in neuroscience
Published: May 08, 2023
Treatment with natalizumab during pregnancy in multiple sclerosis: The experience of implementing a clinical practice protocol (NAP-30).
Journal: Multiple sclerosis and related disorders
Published: May 03, 2022
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.
Journal: Frontiers in immunology
Published: December 23, 2021
Erratum to "Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm" [Neurologia. 2020;35(6):357-362].
Journal: Neurologia
Published: August 18, 2020
Last Updated: 09/26/2026